Critical pathways to success in CNS drug development /

Saved in:
Bibliographic Details
Other Authors: Cutler, Neal R.
Format: Book
Language:English
Published: Chichester, UK ; Hoboken, NJ : Wiley-Blackwell, 2010.
Subjects:
Online Access:Publisher description
Table of contents only
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 01762cam a2200337 a 4500
001 vtls027041287
003 UPM
005 20161022205824.0
008 110420s2010 enka b 001 0 eng
020 |a 9781444330649 (hbk) 
039 9 |a 201107071553  |b medic  |y 201104201057  |z si 
040 |a DNLM/DLC  |c DLC  |d DLC 
060 0 0 |a QV 76.5 C934 2010 
245 0 0 |a Critical pathways to success in CNS drug development /  |c Neal R. Cutler ... [et al.]. 
260 |a Chichester, UK ;  |a Hoboken, NJ :  |b Wiley-Blackwell,  |c 2010. 
300 |a 263p. :  |b ill. ;  |c 23cm. 
505 0 |a The impending crisis in CNS drug development -- Animal models and procedures for CNS disorders -- Pre-clinical antecedents to early human clinical trials -- Biomarkers and surrogate markers in drug development -- Neuroimaging and cognitive assessments in early drug development -- Bridging and CSF studies -- A case study from pre-clinical to early clinical trials. 
650 0 |a Neuropsychopharmacology. 
650 0 |a Drug development. 
650 0 |a Critical path analysis. 
650 0 |a Central nervous system  |x Effect of drugs on  |x Research  |x Methodology. 
650 1 2 |a Central Nervous System Agents  |x pharmacology. 
650 2 2 |a Clinical Trials as Topic  |x methods. 
650 2 2 |a Drug Evaluation  |x methods. 
650 2 2 |a Drug Evaluation, Preclinical  |x methods. 
700 1 |a Cutler, Neal R. 
856 4 2 |3 Publisher description  |u http://www.loc.gov/catdir/enhancements/fy1002/2009035146-d.html 
856 4 1 |3 Table of contents only  |u http://www.loc.gov/catdir/enhancements/fy1002/2009035146-t.html 
942 |2 lcc  |c 20000 
999 |c 358916  |d 358916 
952 |0 0  |1 0  |4 0  |6 QV00765 C934 02010  |7 0  |9 476033  |a 20000  |b 20000  |c 20000  |d 2016-10-22  |o QV 76.5 C934 2010  |p 1000658660  |r 2016-10-22  |w 2016-10-22  |y 20000  |x 1